Skip to main content

Table 11 Compliance of the participants

From: The cost-effectiveness analysis of JinQi Jiangtang tablets for the treatment on prediabetes: a randomized, double-blind, placebo-controlled, multicenter design

Group \( \overline{x}\pm S \) Z P
The treatment group 92.94 ± 7.28 −0.771 0.441
The control group 92.27 ± 8.29